Many cell types are thought to contribute to the generation of an immunosuppressive tumor microenvironment (TME) including cancer-associated fibroblasts, myeloid-derived suppressor cells, regulatory T cells, and tumor-associated macrophages. Read below for a brief description of each cell type and the mechanisms by which they contribute to immune suppression. Click the links to browse our offering of relevant proteins, antibodies, ELISAs, kits, and small molecules.
Trust our Industry-leading Cytokines! CXCL12-mediated Chemoattraction of pro-B Cells Expressing CXCR4 |
CAFs, which can be identified by expression of the membrane protein Fibroblast Activation Protein alpha/FAP, suppress anti-tumor immune responses by restricting T cells to the stroma and preventing them from accumulating in the vicinity of cancer cells by at least two mechanisms:
TAMs are involved in tumor-promoting angiogenesis, fibrous stroma deposition, and metastasis formation. Both M1- and M2-polarized macrophages have been identified in the TME. The mechanisms by which TAMs induce immune suppression are not completely understood, but they likely involve the following:
Simplify Your Immune Cell Differentiation!Differentiation of CD4+ T Cells into Treg Cells using the CellXVivo™ Human Treg Cell Differentiation Kit |
Download our MDSC Brochure |
MDSCs are a heterogenous population of immature myeloid progenitor cells that fail to differentiate into granulocytes, macrophages, and dendritic cells. MDSCs display immunosuppressive properties that are thought to create or contribute to the immunosuppressive TME. MDSC-mediated immune suppressive mechanisms include:
Download our Treg Brochure |
Tregs are a heterogeneous subset of CD4+ T cells with suppressive properties that play a central role in maintaining immune homeostasis and self-tolerance, dampening inflammation, and preventing autoimmunity. Tregs also represent a significant suppressive population in tumors and they function by inhibiting the activities of CD4+ and CD8+ effector T cells, natural killer cells, NKT cells, and antigen-presenting cells through multiple mechanisms including: